DJIA, S&P 500 Slip as NASDAQ Falls Amid Corporate Earnings

Michael Teague  |

The nonchalance of Carl Icahn in his Tuesday evening CNBC interview, as he was handed and then proceeded to sip on a martini, was of no solace to investors in Wednesday’s trading session, as stocks slipped across the board by the closing bell.

While the Dow and S&P ended only modestly lower, the NASDAQ was dragged further asunder by tech shares, as companies throughout the sector pared back gains from previous sessions.

Ahead of a much-anticipated earnings statement from Apple (AAPL) , economic data in the form of drastically lower housing sales for the month of March, an anemic preliminary reading on US manufacturing, and poor results from AT&T (T) and Amgen (AMGN) held the broader market back.

Results for April 23, 2014

●     Standard & Poor’s 500: -0.22 percent to 1,875.39

●     NASDAQ: -0.83 percent to 4,126.97

●     Dow Jones Industrial Average: -0.08 percent to 16,501.65

Our Top Stories

●     Senior Editor Joel Anderson breaks down options-investing.

●     Tim Melvin helps readers avoid being taken for a ride in the thick of earnings season.

●     Senior Editor Michael Teague provides a quasi-psychoanalytic analysis of Silicon Valley’s newest escape vehicle Tsunamiball in the context of the new tech bubble many have been warning of.

●     As a reminder of the growing importance of offshore oil and gas production, readers should have a look at this National Geographic documentary about Royal Dutch Shell’s ($RDS.A) Gulf of Mexico Perdido well.

●     A handy infographic detailing seven basic mistakes made by retirement-investors.

Stocks

●     Some of the components of Equities.com’s Small-Cap Stars index, including Plug Power (PLUG) , are handily outperforming the broader small-cap market in 2014, and this despite the recent downturn in growth-stocks.

●     Senior Editor Jacob Harper revisits breakout micro-cap tech stocks.

●     A reminder that three IPOs were rescheduled from last week to the current one: Scynexis ($SCYX), Quotient ($QTNT), and Aldeyra Therapeutics ($ALDX).

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Trending Articles

Bond Yields Have Risen Well Above Stock Dividend Yields. Are They a Buy?
We're at the Tail End of a Classic Video Game Stock Bust
Is Gold Really the Right Place for Your Money?
How Companies Can Succeed in AI Winter: Jeff Kagan
Utility Investing Is a Steady, Buy-and-Hold Play. Just Not in This Market
Why Nuclear Energy Is Now Part of The Road to Renewables
Our Inflation Nightmare Will Flatline in Six Months
California Wants 100% Electric Vehicles By 2035. Will Its Energy Grid Be Ready?

Market Movers

Sponsored Financial Content